JESSICA BENNETT: Open Payments
NPI 1346870458 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 30 payments from 10 companies in 2025. Trend: 2023 $467 · 2024 $649 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $150 |
| Novartis Pharmaceuticals Corporation | 7 | $135 |
| ABBVIE INC. | 4 | $59 |
| Novo Nordisk Inc | 3 | $52 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Amgen Inc. | 2 | $29 |
| Ardelyx, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: HETLIOZ, LEQVIO, Ozempic, TZIELD, CAPLYTA, QULIPTA, OTEZLA, VRAYLAR.
Industry payments across KY — which companies pay providers there.
